Finance

Lists
RIGL:NASDAQ
Rigel Pharmaceuticals Inc
47,09 $
+0,96%
(+0,45) 1D
47,09 $
0,00% (0,00)
After hours
Closed: 21 սեպ, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for RIGL...
Open
47,13 $
High
47,50 $
Low
46,49 $
Mkt. cap
879,63 մլն
Avg. vol.
293,96 հզր
Volume
0,00
P/E ratio
2,94
52-wk high
52,24 $
52-wk low
24,95 $
EPS
16,04 $
Beta
1,20
Shares outstanding
18,68 մլն
No. of employees
173
Open
47,13 $
High
47,50 $
Low
46,49 $
Mkt. cap
879,63 մլն
Avg. vol.
293,96 հզր
Volume
0,00
P/E ratio
2,94
52-wk high
52,24 $
52-wk low
24,95 $
EPS
16,04 $
Beta
1,20
Shares outstanding
18,68 մլն
No. of employees
173
About Rigel Pharmaceuticals Inc
CEO-
Employees173
Founded1996
HeadquartersSouth San Francisco, Կալիֆոռնիա, Միացյալ Նահանգներ
Sector-
Websiterigel.com
Analyst ratings
Based on 4 analysts giving stock ratings to RIGL in the past 3 months
Buy
Buy
2
Hold
2
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for RIGL in the last 3 months.
Highest
Current 47,09 $
85,00 $ (+80,51%)
Average
65,00 $ (+38,03%)
Lowest
43,00 $ (-8,69%)
Analyst
Recommendation
Action
Price target
Projected
Date
Joseph Pantginis
H.C. Wainwright
Buy
Reiterated
85,00 $
+80,5%
09/08/2026
Allison Bratzel
Piper Sandler
Hold
Maintained
49,00 $
+4,1%
08/17/2026
Yigal Nochomovitz
Citi
Buy
Maintained
83,00 $
+76,3%
08/06/2026
Kristen Kluska
Cantor Fitzgerald
Hold
Maintained
43,00 $
-8,7%
08/04/2026
Last report
04 օգս, 2026 թ.
Fiscal period
Q2 2026
EPS / Est. (USD)
0,88 $ / -0,08 $
+1 266,80%beat
Revenue / Est. (USD)
78,70 մլն / 55,27 մլն
+42,39%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
69,46 մլն
69,80 մլն
58,82 մլն
78,70 մլն
Cost of goods sold
12,11 մլն
16,64 մլն
16,28 մլն
22,49 մլն
Cost of revenue
12,11 մլն
16,64 մլն
16,28 մլն
22,49 մլն
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
28,94 մլն
29,99 մլն
30,65 մլն
32,64 մլն
Operating expense
28,94 մլն
29,99 մլն
30,65 մլն
32,64 մլն
Total operating expenses
41,04 մլն
46,63 մլն
46,93 մլն
55,13 մլն
Operating income
28,42 մլն
23,17 մլն
11,88 մլն
23,58 մլն
Other non operating income
-
-
-
-
EBT including unusual items
27,62 մլն
22,71 մլն
11,66 մլն
23,58 մլն
EBT excluding unusual items
27,62 մլն
22,71 մլն
11,66 մլն
23,58 մլն
Income tax expense
-280,00 հզր
-245,35 մլն
3,00 մլն
6,30 մլն
Effective tax rate
-1,01%
-1 080,18%
25,76%
26,69%
Other operating expenses
-
-
-
-
Net income
27,90 մլն
268,06 մլն
8,65 մլն
17,29 մլն
Net profit margin
40,17%
384,04%
14,71%
21,97%
Earnings per share
1,46
1,12
0,44
0,88
Interest and investment income
1,09 մլն
1,24 մլն
1,20 մլն
789,00 հզր
Interest expense
-1,89 մլն
-1,70 մլն
-1,43 մլն
-779,00 հզր
Net interest expenses
-800,00 հզր
-456,00 հզր
-228,00 հզր
10,00 հզր
Depreciation and amortization charges
-
-
-
-
EBITDA
29,02 մլն
23,77 մլն
12,48 մլն
24,42 մլն
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google Apps